Since 01 January 2012, influenza A(H1N1)pdm09, influenza A(H3N2) and influenza B/Victoria and B/Yamagata lineage viruses have been detected in ECDC-affiliated countries.

• Type A viruses have predominated over type B.
• A(H3N2) viruses have predominated over A(H1N1)pdm09 viruses.
• A(H1N1)pdm09 viruses continue to show genetic drift from the vaccine virus, A/California/07/2009, but the vast majority remain antigenically similar to it.
• During the last nine months, all European A(H3N2) viruses sequenced fell within five genetic clusters. Test viruses
  isolated in mammalian cells show low titres with post-infection ferret antisera raised against egg-propagated viruses, including the new vaccine virus A/Victoria/361/2011. They react well with post-infection ferret antisera raised against A/Victoria/361/2011 and other current reference viruses propagated exclusively in tissue culture.
• Recent B/Victoria lineage viruses fell within the B/Brisbane/60/2008 genetic clade and were antigenically similar to reference cell-propagated viruses of the B/Brisbane/60/2008 genetic clade.
• Recent B/Yamagata-lineage viruses fell into two genetic clades, represented by the recommended vaccine component for the 2012/2013 influenza season, B/Wisconsin/1/2010 (clade 3), or B/Estonia/55669/2012 (clade 2); viruses in these clades are antigenically distinguishable.
• Antigenic analyses of A(H3N2)v viruses, the cause of zoonotic infections in the USA, indicate that these viruses are antigenically distinct from seasonal A(H3N2) viruses.